3649 views | 3 years ago
The Illumina Polygenic Risk Score solution is a comprehensive, easy-to-implement, and versatile genomic analysis tool set for translational researchers. Featuring the Infinium Global Diversity Array...
3220 views | 3 years ago
The NovaSeq 6000Dx offers immense diagnostic power in an FDA-registered, CE-marked next-generation sequencing platform. From an integrated, unified interface, users can run the NovaSeq 6000Dx instrument...
952 views | 3 years ago
Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions...
2033 views | 3 years ago
Isabelle Ray-Coquard, MD, PhD, explains how comprehensive genomic profiling (CGP) simultaneously provides HRD and _BRCA_ status in ovarian cancer patients. She presents the case of a patient who benefited...
1094 views | 3 years ago
Vivek Subbiah, MD, explains how patients with rare and common tumors can benefit from next-generation-sequencing-based testing for _NTRK_ gene fusions. He presents the case of a patient who benefited...
3136 views | 3 years ago
Maximize genomic insights with Illumina DRAGEN™. DRAGEN offers accurate, comprehensive, and efficient secondary analysis of next-generation sequencing data. #Illumina #DRAGEN #oncogenomics Learn More:...
366 views | 3 years ago
As next-generation sequencing and other technologies have advanced, cancer care has improved dramatically. More sophisticated diagnostics, targeted treatments, immunotherapies and other approaches are...
38 views | 3 years ago
As next-generation sequencing and other technologies have advanced, cancer care has improved dramatically. More sophisticated diagnostics, targeted treatments, immunotherapies and other approaches are...